References
- Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharm J. 2015;23(6):587–602.
- Aqil M, Sultana Y, Ali A. Transdermal delivery of β-blockers. Expert Opin Drug Deliv. 2006;3(3):405–18.
- Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91(9):2076–89.
- Calatayud-Pascual MA, Sebastian-Morelló M, Balaguer-Fernández C, Delgado-Charro MB, López-Castellano A, Merino V. Influence of chemical enhancers and iontophoresis on the in vitro transdermal permeation of propranolol: Evaluation by dermatopharmacokinetics. Pharmaceutics. 2018;10(4).
- Costa P, Sousa Lobo JM. Modeling and Comparison of Dissolution Profiles. Eur J Pharm Sci. 2001;13(2):123–133.
- Dey BK, Kar PK, Nath LK. Formulation design, preparation and in vitro – in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex. Research J. Pharm. and Tech. 2009;2(1):155–160.
- European pharmacopoeia 10.4. 2.9.4. Dissolution test for transdermal patches. (https://pheur.edqm.eu/app/10-4/content/10-4/20904E.htm?highlight=on&terms=dissolution). Revised April 2021. Accessed June 7, 2021.
- Levis SR, Deasy PB. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int J Pharm. 2003;253(1–2):145–57.
- Sanap GS, Dama GY, Hande AS et al. Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green Pharm. 2008;2(2):129.